Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (95)	5/3/2001 11:30:13 PM
From: JFitnich	Read Replies (2) \| Respond to of 598

Tuck, I had some notes, or thought I had some :) The CCall as you expected delivered nothing earth shattering. Products are progressing through trials. Q & A One question had to do with the discontinuation of the Knoll deal in Obesity. It sounded like the work on this project would be reverting back to TLRK when the deal ends in October. Another question consisted of the direction of the board, Levin (MLNM) is vacating his spot as is Sjostrand. No reason was given, mgmt stated that they would be looking at getting replacements in the future. 10-K stated that MLNM is working on competitive projects to TLRK's. (Although this could be just about any biotech as far as MLNM's pipe is concerned, but I see where conflict of interest may arise.) Sorry I don't have more. Just a mishmash from my memory. If anybody has anything else, please contribute. JF